Correlation Between Protalix Biotherapeutics and Reviva Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Protalix Biotherapeutics and Reviva Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Protalix Biotherapeutics and Reviva Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Protalix Biotherapeutics and Reviva Pharmaceuticals Holdings, you can compare the effects of market volatilities on Protalix Biotherapeutics and Reviva Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Protalix Biotherapeutics with a short position of Reviva Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Protalix Biotherapeutics and Reviva Pharmaceuticals.
Diversification Opportunities for Protalix Biotherapeutics and Reviva Pharmaceuticals
0.55 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Protalix and Reviva is 0.55. Overlapping area represents the amount of risk that can be diversified away by holding Protalix Biotherapeutics and Reviva Pharmaceuticals Holding in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Reviva Pharmaceuticals and Protalix Biotherapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Protalix Biotherapeutics are associated (or correlated) with Reviva Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Reviva Pharmaceuticals has no effect on the direction of Protalix Biotherapeutics i.e., Protalix Biotherapeutics and Reviva Pharmaceuticals go up and down completely randomly.
Pair Corralation between Protalix Biotherapeutics and Reviva Pharmaceuticals
Considering the 90-day investment horizon Protalix Biotherapeutics is expected to generate 2.59 times less return on investment than Reviva Pharmaceuticals. But when comparing it to its historical volatility, Protalix Biotherapeutics is 3.0 times less risky than Reviva Pharmaceuticals. It trades about 0.33 of its potential returns per unit of risk. Reviva Pharmaceuticals Holdings is currently generating about 0.29 of returns per unit of risk over similar time horizon. If you would invest 10.00 in Reviva Pharmaceuticals Holdings on September 1, 2024 and sell it today you would earn a total of 12.00 from holding Reviva Pharmaceuticals Holdings or generate 120.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Protalix Biotherapeutics vs. Reviva Pharmaceuticals Holding
Performance |
| Timeline |
| Protalix Biotherapeutics |
| Reviva Pharmaceuticals |
Protalix Biotherapeutics and Reviva Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Protalix Biotherapeutics and Reviva Pharmaceuticals
The main advantage of trading using opposite Protalix Biotherapeutics and Reviva Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Protalix Biotherapeutics position performs unexpectedly, Reviva Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Reviva Pharmaceuticals will offset losses from the drop in Reviva Pharmaceuticals' long position.| Protalix Biotherapeutics vs. Corvus Pharmaceuticals | Protalix Biotherapeutics vs. Aldeyra | Protalix Biotherapeutics vs. Checkpoint Therapeutics | Protalix Biotherapeutics vs. Cidara Therapeutics |
| Reviva Pharmaceuticals vs. Reviva Pharmaceuticals Holdings | Reviva Pharmaceuticals vs. CannBioRx Life Sciences | Reviva Pharmaceuticals vs. Clene Inc | Reviva Pharmaceuticals vs. Lixte Biotechnology Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Other Complementary Tools
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |